Roberto Bolli MD
Adult Congenital Heart Disease
Professor, Medicine, University of Louisville School of Medicine
Join to view full profile
201 Abraham Flexner Way1001Louisville, KY 40202
Phone+1 502-587-4500
Fax+1 502-587-4146
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Roberto Bolli, MD is a cardiologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Texas. He is a Professor at University of Louisville School of Medicine.
Education & Training
Baylor College of MedicineResidency, Internal Medicine, 1981 - 1983
University of Perugia Faculty of MedicineClass of 1976- Baylor College of MedicineFellowship, Cardiovascular Disease
Certifications & Licensure
KY State Medical License 1995 - 2027
TX State Medical License 1984 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 39 citationsTrials and tribulations of cell therapy for heart failure: an update on ongoing trials.Jianyi Jay Zhang, Steven M Pogwizd, Keiichi Fukuda, Wolfram-Hubertus Zimmermann, Chengming Fan
Nature Reviews. Cardiology. 2025-05-01 - 14 citationsIntravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.Xian-Liang Tang, Marcin Wysoczynski, Anna M Gumpert, Mitesh Solanki, Yan Li
Cardiovascular Research. 2024-12-04 - 2 citationsCAESAR lives on with IMPACT: bringing rigor and relevance to cardioprotection research.Roberto Bolli, Xian-Liang Tang
Basic Research in Cardiology. 2024-12-01
Press Mentions
Research Study at UofL First in US to Treat Heart Failure with Umbilical Cord Stem CellsDecember 24th, 2024- Years After Brigham-Harvard Scandal, U.S. Pours Millions into Tainted Stem-Cell FieldJune 21st, 2022
- Clinical Trial at UofL Shows Cell Therapy Improves Outcomes in Heart FailureJune 14th, 2021
